Computed tomography and coronary artery calcium score for screening of coronary artery disease and cardiovascular risk management in asymptomatic individuals.
Autor: | Pinto-Sietsma SJ; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Velthuis BK; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands., Nurmohamed NS; Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Vliegenthart R; Department of Radiology, University Medical Center Groningen, Groningen, The Netherlands., Martens FMAC; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands. f.m.a.c.martens@amsterdamumc.nl. |
---|---|
Jazyk: | angličtina |
Zdroj: | Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation [Neth Heart J] 2024 Nov; Vol. 32 (11), pp. 371-377. Date of Electronic Publication: 2024 Oct 02. |
DOI: | 10.1007/s12471-024-01897-1 |
Abstrakt: | Several risk prediction models exist to predict atherosclerotic cardiovascular disease in asymptomatic individuals, but systematic reviews have generally found these models to be of limited utility. The coronary artery calcium score (CACS) offers an improvement in risk prediction, yet its role remains contentious. Notably, its negative predictive value has a high ability to rule out clinically relevant atherosclerotic cardiovascular disease. Nonetheless, CACS 0 does not permanently reclassify to a lower cardiovascular risk and periodic reassessment every 5 to 10 years remains necessary. Conversely, elevated CACS (> 100 or > 75th percentile adjusted for age, sex and ethnicity) can reclassify intermediate-risk individuals to a high risk, benefiting from preventive medication. The forthcoming update to the Dutch cardiovascular risk management guideline intends to re-position CACS for cardiovascular risk assessment as such in asymptomatic individuals. Beyond CACS as a single number, several guidelines recommend coronary CT angiography (CCTA), which provides additional information about luminal stenosis and (high-risk) plaque composition, as the first choice of test in symptomatic patients and high-risk patients. Ongoing randomised studies will have to determine the value of atherosclerosis evaluation with CCTA for primary prevention in asymptomatic individuals. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |